{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:13:17Z","timestamp":1770232397698,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Instituto de Ci\u00eancia e tecnologia para Inova\u00e7\u00e3o Farmac\u00eautica"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cyto.2015.07.016","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T13:16:45Z","timestamp":1437571005000},"page":"310-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of CD4+CD25+FoxP3+ T cell populations, IL-10 production, and their correlation with clinical and biochemical parameters in sickle cell anemia patients with leg ulcers"],"prefix":"10.1016","volume":"75","author":[{"given":"Moacyr Jesus Barreto Melo","family":"R\u00eago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Ramos","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelly Cristiny","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aderson","family":"da Silva Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan da Rocha","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Arruda","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Andr\u00e9 Cavalcanti","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira Galdino da Rocha","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.07.016_b0005","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1056\/NEJMp058274","article-title":"Preventing stroke in sickle cell anemia","volume":"353","author":"Platt","year":"2005","journal-title":"New Engl. Med."},{"key":"10.1016\/j.cyto.2015.07.016_b0010","doi-asserted-by":"crossref","first-page":"H1799","DOI":"10.1152\/ajpheart.2000.278.6.H1799","article-title":"Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse","volume":"278","author":"Kaul","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2015.07.016_b0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.21838","article-title":"Leg ulcers in sickle cell disease","volume":"85","author":"Minniti","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2015.07.016_b0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V74.4.1403.1403","article-title":"Leg ulcers in patients with sickle cell disease","volume":"74","author":"Koshy","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.07.016_b0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/cs0980667","article-title":"Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers","volume":"98","author":"Mohan","year":"2000","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.cyto.2015.07.016_b0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2015.07.016_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2015.07.016_b0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002770000173","article-title":"The role of cytokines in sickle cell disease","volume":"79","author":"Makis","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cyto.2015.07.016_b0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2015.07.016_b0050","first-page":"619","article-title":"In vivo production of type 1 cytokines in healthy sickle cell disease patients","volume":"91","author":"Taylor","year":"1999","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.cyto.2015.07.016_b0055","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood.V92.7.2551","article-title":"Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis","volume":"92","author":"Graido-Gonzalez","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2015.07.016_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cyto.2013.11.012","article-title":"Evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers","volume":"65","author":"Silva","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2015.07.016_b0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2015.07.016_b0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.intimp.2010.11.008","article-title":"FOXP3 and RORgammat: transcriptional regulation of Treg and Th17","volume":"11","author":"Chen","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2015.07.016_b0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1189\/jlb.0606409","article-title":"Control of NK cell functions by CD4+CD25+ regulatory T cells","volume":"81","author":"Ralainirina","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2015.07.016_b0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2015.07.016_b0085","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CVI.00145-09","article-title":"Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis","volume":"17","author":"Musa","year":"2010","journal-title":"Clin. Vaccine Immunol.: CVI"},{"key":"10.1016\/j.cyto.2015.07.016_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cyto.2015.07.016_b0095","first-page":"753","article-title":"Type 2 cytokine serum levels in healthy sickle cell disease patients","volume":"89","author":"Taylor","year":"1997","journal-title":"J. Natl. Med. Assoc."},{"issue":"7","key":"10.1016\/j.cyto.2015.07.016_b0100","doi-asserted-by":"crossref","first-page":"e68929","DOI":"10.1371\/journal.pone.0068929","article-title":"Blood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers","volume":"26;8","author":"Bowers","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2015.07.016_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","article-title":"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection","volume":"16","author":"Said","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2015.07.016_b0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"Grimbaldeston","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2015.07.016_b0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CVI.00145-09","article-title":"Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis","volume":"17","author":"Musa","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2015.07.016_b0120","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V86.11.4382b.bloodjournal86114382b","article-title":"Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia","volume":"86","author":"Knauf","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.07.016_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.cyto.2015.07.016_b0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/ken462","article-title":"Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway","volume":"48","author":"Okazaki","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2015.07.016_b0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-5347(05)65841-7","article-title":"Genitourinary complications of sickle cell disease","volume":"166","author":"Bruno","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.cyto.2015.07.016_b0140","series-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","first-page":"633","article-title":"Priapism","author":"Halkin","year":"1994"},{"key":"10.1016\/j.cyto.2015.07.016_b0145","doi-asserted-by":"crossref","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","article-title":"Cytokines and vascular reactivity in resistance arteries","volume":"288","author":"Vila","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2015.07.016_b0150","doi-asserted-by":"crossref","first-page":"H489","DOI":"10.1152\/ajpheart.00251.2008","article-title":"Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1\/2-dependent pathway","volume":"296","author":"Giachini","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2015.07.016_b0155","doi-asserted-by":"crossref","first-page":"H3103","DOI":"10.1152\/ajpheart.00456.2006","article-title":"Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings","volume":"292","author":"Zemse","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2015.07.016_b0160","doi-asserted-by":"crossref","first-page":"H624","DOI":"10.1152\/ajpheart.01234.2004","article-title":"Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction","volume":"289","author":"Gunnett","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cyto.2015.07.016_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI10726","article-title":"Sickle cell anemia as an inflammatory disease","volume":"106","author":"Platt","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2015.07.016_b0170","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cyto.2015.07.016_b0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.0903314","article-title":"The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells","volume":"186","author":"Fujimoto","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2015.07.016_b0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajh.23629","article-title":"Partial dysfunction of Treg activation in sickle cell disease","volume":"89","author":"Vingert","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.cyto.2015.07.016_b0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.23488","article-title":"Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease","volume":"88","author":"Bao","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2015.07.016_b0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2007.137539","article-title":"Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses","volume":"57","author":"Robinson","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.07.016_b0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0714.2008.00661.x","article-title":"Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis","volume":"37","author":"Lewkowicz","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cyto.2015.07.016_b0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2006.00155.x","article-title":"Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers","volume":"14","author":"Galkowska","year":"2006","journal-title":"Wound Repair Regen."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T13:44:43Z","timestamp":1599313483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615300260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1043466615300260"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.07.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of CD4+CD25+FoxP3+ T cell populations, IL-10 production, and their correlation with clinical and biochemical parameters in sickle cell anemia patients with leg ulcers","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}